Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × durvalumab × Clear all

Phase

Phase 2 16 Phase 1/2 3 Phase 3 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Completed 57 Terminated 20 Recruiting 18 Active not recruiting 18 Withdrawn 7 Unknown 5 Suspended 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Cyclophosphamide 21 fludarabine 16 Specimen Handling 12 Nivolumab 11 pembrolizumab 10 Cisplatin 8 Magnetic Resonance Spectroscopy 7 tislelizumab 6 Radiotherapy 6 Injections 6 X-Rays 5 Interleukin-2 5 Doxorubicin 5 Carboplatin 5 venetoclax 4 fludarabine phosphate 4 daratumumab 4 Rituximab 4 Radiosurgery 4 Ipilimumab 4 Immunotherapy, Adoptive 4 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Fluorouracil 4 Decitabine 4 Biopsy 4 toripalimab 3 Vincristine 3 Prednisone 3 Melphalan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07531095 2026-04-15

DeLLphi-313

Amgen

Phase 1 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡